# Resection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System Treatment

> **NCT04066322** · — · UNKNOWN · sponsor: **Fudan University** · enrollment: 180 (estimated)

## Conditions studied

- Neuroendocrine Tumors
- Metastases
- Surgery

## Interventions

- **PROCEDURE:** system treatment and surgery
- **OTHER:** system treatment

## Key facts

- **NCT ID:** NCT04066322
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-25
- **Primary completion:** 2024-07-25
- **Final completion:** 2025-07-25
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066322, "Resection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04066322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*